Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (72)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Meade, T W
Right arrow Articles by Berra, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meade, T W
Right arrow Articles by Berra, A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 48:276-308 (1992)
© 1992 The British Council

other

Hormone replacement therapy and cardiovascular disease

T W Meade and A Berra

MRC Epidemiology and Medical Care Unit, Northwick Park Hospital Harrow, UK

Abstract

Oestrogen alone probably confers a degree of protection against ischaemic heart disease and stroke and is appropriate for women requiring hormone replacement therapy (HRT) who have undergone hysterectomy. However, the cardiovascular effects of the progestogens used with oestrogen in the much larger number of women who have not undergone hysterectomy are unknown. Some widely used progestogens have adverse effects on lipoprotein levels and may raise blood pressure. The antithrombin III level may be involved in determining the response to oestrogen in different settings. The indications for HRT and the effects of different formulations on cardiovascular disease constitute one of the most pressing but complex issues in present-day medical practice. These questions can only be satisfactorily answered by the randomised controlled trials that should have been initiated several years ago and the feasibility of which is only now being investigated.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Holist NursHome page
C. J. Matarese
Navigating the Journey to Menses Cessation: A Study of Change in an Emancipatory Context
J Holist Nurs, March 1, 2005; 23(1): 34 - 50.
[Abstract] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
N. Acs, Z. Vajo, Z. Miklos, G. Siklósi, F. Paulin, and B. Szekacs
Postmenopausal Hormone Replacement Therapy and Cardiovascular Mortality in Central-Eastern Europe
J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2000; 55(3): 160M - 162.
[Abstract] [Full Text]

Home page
 Fam PractHome page
M. Lawrence, L. Jones, T. Lancaster, E. Daly, and E. Banks
Hormone replacement therapy: patterns of use studied through British general practice computerized records
Fam. Pract., August 1, 1999; 16(4): 335 - 342.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
A. M. Hales, C. G. Chamberlain, C. R. Murphy, and J. W. McAvoy
Estrogen Protects Lenses against Cataract Induced by Transforming Growth Factor-{beta} (TGF{beta})
J. Exp. Med., January 20, 1997; 185(2): 273 - 280.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. G. Thrift, J. J. McNeil, A. Forbes, and G. A. Donnan
Risk Factors for Cerebral Hemorrhage in the Era of Well-Controlled Hypertension
Stroke, November 1, 1996; 27(11): 2020 - 2025.
[Abstract] [Full Text]

Home page
 BMJHome page
H S Jacobs
Controversies in Management: Not for everybody
BMJ, August 10, 1996; 313(7053): 351 - 352.
[Full Text]

Home page
 BMJHome page
Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy
BMJ, February 24, 1996; 312(7029): 473 - 478.
[Abstract] [Full Text]

Home page
 BMJHome page
W F M Potshuma, R G J Westendorp, and J P Vandenbroucke
Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?
BMJ, May 14, 1994; 308(6939): 1268 - 1269.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
M. R. Soma, I. Osnago-Gadda, R. Paoletti, R. Fumagalli, J. D. Morrisett, M. Meschia, and P. Crosignani
The Lowering of Lipoprotein[a] Induced by Estrogen Plus Progesterone Replacement Therapy in Postmenopausal Women
Arch Intern Med, June 28, 1993; 153(12): 1462 - 1468.
[Abstract] [PDF]

Home page
 JAMAHome page
E. Barrett-Connor and D. Kritz-Silverstein
Estrogen Replacement Therapy and Cognitive Function in Older Women
JAMA, May 26, 1993; 269(20): 2637 - 2641.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.